SCHEMBL29786259

SCHEMBL29786259

Fc1ccc(-c2c[nH]cn2)cn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.45
CYP2A6 P11509 3/20 0.42
CYP2B6 P20813 3/20 0.42
CYP2E1 P05181 1/20 0.42
JAK2 O60674 1/20 0.41
RET P07949 1/20 0.41
KDR P35968 1/20 0.41
GSK3A P49840 1/20 0.41
RPS6KA3 P51812 1/20 0.41
LIMK1 P53667 1/20 0.41
MAP2K1 Q02750 1/20 0.41
DYRK1A Q13627 1/20 0.41
MAPK14 Q16539 1/20 0.41
CLK4 Q9HAZ1 1/20 0.41
ALK Q9UM73 1/20 0.41
DYRK1B Q9Y463 1/20 0.41
CYP3A4 P08684 2/20 0.39
CYP2C19 P33261 2/20 0.39
KDM5B Q9UGL1 1/20 0.37
SYK P43405 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4865443 1.00 MAPT (0.45) MAPTCYP2A6CYP2B6CYP2E1JAK2
SCHEMBL29786258 0.78 CYP19A1 (0.40) CHRNB2CHRNA4
SCHEMBL23124011 0.78 CYP19A1 (0.40) CHRNB2CHRNA4
SCHEMBL4868679 0.77 PIK3CD (0.46) CYP2A6CYP3A4CHRNB2CHRNB4CHRNA3
SCHEMBL4862787 0.77 HPGDS (0.44) MAPTMAPK14SYKCHRNB2CHRNB4
SCHEMBL20054187 0.77 AKT1 (0.30)
SCHEMBL30641497 0.77 TRPV4 (0.44) KDM5BPDE3BPDE3A
Hydrochloric Acid SCHEMBL15367017 0.76 HPGDS (0.43) MAPTMAPK14SYKCHRNB2CHRNB4
SCHEMBL26104326 0.73 CYP2A6 (0.64) MAPTCYP2A6CYP2B6CYP2E1JAK2
SCHEMBL23123510 0.73 KDM5B (0.40) KDRKDM5BSYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4031531-A1 SUBSTITUTED IMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS Bial-R&D Investments, S.A. (PT) 2022-07-27 EP disclosed
CN-114787135-A Substituted imidazole carboxamides and their use in the treatment of medical disorders 比亚尔R&D投资股份公司 2022-07-22 CN disclosed